Valuation : DiaSorin S.p.A.

Market Cap 3.79B 4.4B 3.56B 3.25B 6.12B 421B 6.13B 42.19B 16.46B 212B 16.52B 16.17B 704B P/E 2026 *
22.2x
P/E 2027 * 19.6x
Enterprise Value 4.5B 5.22B 4.22B 3.85B 7.25B 499B 7.28B 50.05B 19.53B 252B 19.6B 19.18B 835B EV / Sales 2026 *
3.64x
EV / Sales 2027 * 3.31x
Free-Float
37.17%
Yield 2026 *
1.7%
Yield 2027 * 1.78%
1 day-0.49%
1 week+1.97%
Current month+6.62%
1 month+8.50%
3 months+14.70%
6 months+7.61%
Current year+11.66%
1 week 74.7
Extreme 74.7
77.5
1 month 68.74
Extreme 68.74
77.5
Current year 52.34
Extreme 52.34
77.64
1 year 52.34
Extreme 52.34
86.34
3 years 52.34
Extreme 52.34
112.35
5 years 52.34
Extreme 52.34
208.8
10 years 49.98
Extreme 49.98
211.8
Manager TitleAgeSince
Chief Executive Officer 60 26/03/2007
Director of Finance/CFO - 01/01/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 28/04/2016
Director/Board Member 63 26/03/2007
Chairman 57 29/04/2022
Date Insider Type Main position Quantity % Market Cap.
3/24/26 A Buy

Chief Executive Officer

9,211 0.0165%
1/28/26 A Buy

Chief Executive Officer

7,500 0.0134%
1/8/26 A Buy

Director

700 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
-0.49%+1.97%-10.91%-19.13% 4.4B
-4.17%-5.38%+150.50%+322.55% 21.67B
-0.33%+1.01%-36.12%-21.75% 10.28B
-5.10%-5.50%+330.95%+30.27% 8.02B
-2.84%-2.44%-32.96% - 7.24B
+0.30%+0.80%+81.57%+51.76% 6.58B
+2.72%+0.56%-11.59%-13.28% 6.09B
-2.23%-4.02%+71.41%+102.27% 4.23B
-1.34%-4.42%-18.97%-26.20% 2.81B
-0.88%+4.89%-30.65%-36.08% 1.35B
Average -1.44%-0.57%+49.32%+43.38% 7.27B
Weighted average by Cap. -2.11%-1.99%+81.61%+114.56%

Financials

2026 *2027 *
Net sales 1.23B 1.43B 1.16B 1.06B 1.99B 137B 2B 13.73B 5.36B 69.11B 5.38B 5.26B 229B 1.31B 1.52B 1.23B 1.12B 2.11B 145B 2.12B 14.57B 5.68B 73.33B 5.71B 5.58B 243B
Net income 181M 210M 169M 155M 291M 20.03B 292M 2.01B 784M 10.11B 787M 770M 33.52B 205M 238M 193M 176M 331M 22.79B 332M 2.29B 892M 11.51B 895M 876M 38.15B
Net Debt 707M 820M 662M 605M 1.14B 78.37B 1.14B 7.86B 3.07B 39.56B 3.08B 3.01B 131B 541M 628M 508M 463M 873M 60.05B 876M 6.02B 2.35B 30.31B 2.36B 2.31B 101B
Logo DiaSorin S.p.A.
DiaSorin SpA is an Italy-based company engaged in healthcare industry. The Company specializes in provision of developing, producing and commercializing reagent kits for the in vitro diagnostics. The Company develops and manufactures reagents for in vitro diagnostics and produces products for the fields of infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity. The Company’s business activities are divided into two markets. The Immunodiagnostics market develops, produces and markets immunoreagent kits, which are based on three techniques: Chemiluminescence (CLIA), Colorimetry (ELISA) and Radioimmunometry (RIA). The Molecular Diagnostics market supplies end laboratories with an automated result to perform the three steps for the final diagnostic result, including nucleic acids extraction, amplification and diagnosis. It operates through ELISA immunodiagnostic business portfolio.
Employees
3,260
Date Price Change Volume
28/08/26 €76.62 -0.49% 170,669
27/08/26 €77.00 +1.77% 183,344
26/08/26 €75.66 -0.39% 116,144
25/08/26 €75.96 +0.64% 64,276
24/08/26 €75.48 +0.45% 125,240
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
76.62EUR
Average target price
71.66EUR
Spread / Average Target
-6.47%

Quarterly revenue - Rate of surprise